Literature DB >> 8641760

Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria.

A A Lal1, M A Hughes, D A Oliveira, C Nelson, P B Bloland, A J Oloo, W E Hawley, A W Hightower, B L Nahlen, V Udhayakumar.   

Abstract

AMA-1 of Plasmodium falciparum is a promising candidate antigen in malaria vaccine development. In this study, we have mapped the immunodominant T-cell determinants in this antigen by using synthetic peptides. From the amphipathic scores, 17 putative T-cell determinants were identified. Nine of the 17 peptides complementary to the putative T-cell determinants induced proliferation of peripheral blood mononuclear cells (PBMC) from Kenyan residents who had lifelong exposure to malaria; none of these peptides induced proliferation of PBMC from donors who were not previously exposed to malaria. This indicates that AMA-1 peptides were stimulating T cells that were previously primed by prior exposure to P. falciparum. Many positive responders showed reactivity to more than one peptide, and some of the potent proliferative T epitopes were found to be localized in the highly conserved regions of AMA-1, suggesting that it may be possible to induce T-cell memory that can recognize different variant forms of the parasite. This information on the natural immune responses against the AMA-1 vaccine antigen in clinically immune adults will be helpful in the development of an AMA-1 antigen-based malaria vaccine and may also guide testing of AMA-1-based vaccine formulations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641760      PMCID: PMC173881          DOI: 10.1128/iai.64.3.1054-1059.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein.

Authors:  M J Lockyer; K Marsh; C I Newbold
Journal:  Mol Biochem Parasitol       Date:  1989-12       Impact factor: 1.759

2.  Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.

Authors:  W E Collins; D Pye; P E Crewther; K L Vandenberg; G G Galland; A J Sulzer; D J Kemp; S J Edwards; R L Coppel; J S Sullivan
Journal:  Am J Trop Med Hyg       Date:  1994-12       Impact factor: 2.345

3.  Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea.

Authors:  D L Doolan; H P Beck; M F Good
Journal:  Parasite Immunol       Date:  1994-03       Impact factor: 2.280

4.  Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi.

Authors:  J A Deans; T Alderson; A W Thomas; G H Mitchell; E S Lennox; S Cohen
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

5.  Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials.

Authors:  J C Beier; P V Perkins; F K Onyango; T P Gargan; C N Oster; R E Whitmire; D K Koech; C R Roberts
Journal:  J Med Entomol       Date:  1990-07       Impact factor: 2.278

6.  Immune response in patients during and after Plasmodium falciparum infection.

Authors:  P G Kremsner; G M Zotter; H Feldmeier; W Graninger; R M Rocha; R Jansen-Rosseck; U Bienzle
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

7.  CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.

Authors:  A Moreno; P Clavijo; R Edelman; J Davis; M Sztein; F Sinigaglia; E Nardin
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

8.  Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites.

Authors:  I A Quakyi; J Currier; A Fell; D W Taylor; T Roberts; R A Houghten; R D England; J A Berzofsky; L H Miller; M F Good
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

9.  Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum.

Authors:  M Ho; H K Webster; S Looareesuwan; W Supanaranond; R E Phillips; P Chanthavanich; D A Warrell
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

10.  The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes.

Authors:  A W Thomas; J A Deans; G H Mitchell; T Alderson; S Cohen
Journal:  Mol Biochem Parasitol       Date:  1984-10       Impact factor: 1.759

View more
  22 in total

1.  Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.

Authors:  Thilan Wickramarachchi; Prasad H Premaratne; K L R Lakshman Perera; Sumith Bandara; Clemens H M Kocken; Alan W Thomas; Shiroma M Handunnetti; Preethi V Udagama-Randeniya
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Authors:  Lyticia A Ochola; Cyrus Ayieko; Lily Kisia; Ng'wena G Magak; Estela Shabani; Collins Ouma; Chandy C John
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

3.  Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya.

Authors:  Faith H A Osier; Gareth D Weedall; Federica Verra; Linda Murungi; Kevin K A Tetteh; Pete Bull; Bart W Faber; Ed Remarque; Alan Thomas; Kevin Marsh; David J Conway
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

4.  Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.

Authors:  Sophie Schussek; Angela Trieu; Simon H Apte; John Sidney; Alessandro Sette; Denise L Doolan
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

5.  Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.

Authors:  Sheetij Dutta; P V Lalitha; Lisa A Ware; Arnoldo Barbosa; J Kathleen Moch; Meredith A Vassell; Bader B Fileta; Svetlana Kitov; Nelly Kolodny; D Gray Heppner; J David Haynes; David E Lanar
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Helper T-cell epitopes encoded by the Babesia bigemina rap-1 gene family in the constant and variant domains are conserved among parasite strains.

Authors:  W C Brown; T F McElwain; I Hötzel; C E Suarez; G H Palmer
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

7.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein.

Authors:  Martha Sedegah; Yohan Kim; Bjoern Peters; Shannon McGrath; Harini Ganeshan; Jennylynn Lejano; Esteban Abot; Glenna Banania; Maria Belmonte; Renato Sayo; Fouzia Farooq; Denise L Doolan; David Regis; Cindy Tamminga; Ilin Chuang; Joseph T Bruder; C Richter King; Christian F Ockenhouse; Bart Faber; Edmond Remarque; Michael R Hollingdale; Thomas L Richie; Alessandro Sette
Journal:  Malar J       Date:  2010-08-24       Impact factor: 2.979

9.  Alanine mutagenesis of the primary antigenic escape residue cluster, c1, of apical membrane antigen 1.

Authors:  Sheetij Dutta; Lisa S Dlugosz; Joshua W Clayton; Christopher D Pool; J David Haynes; Robert A Gasser; Adrian H Batchelor
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

10.  Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial.

Authors:  Kirsten E Lyke; Modibo Daou; Issa Diarra; Abdoulaye Kone; Bourema Kouriba; Mohamadou A Thera; Sheetij Dutta; David E Lanar; D Gray Heppner; Ogobara K Doumbo; Christopher V Plowe; Marcelo B Sztein
Journal:  Vaccine       Date:  2009-01-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.